153 related articles for article (PubMed ID: 17210815)
1. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.
Sevigny JJ; Albert SM; McDermott MP; Schifitto G; McArthur JC; Sacktor N; Conant K; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Marder K; Epstein LG
Arch Neurol; 2007 Jan; 64(1):97-102. PubMed ID: 17210815
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
3. Markers of immune activation and viral load in HIV-associated sensory neuropathy.
Schifitto G; McDermott MP; McArthur JC; Marder K; Sacktor N; McClernon DR; Conant K; Cohen B; Epstein LG; Kieburtz K;
Neurology; 2005 Mar; 64(5):842-8. PubMed ID: 15753420
[TBL] [Abstract][Full Text] [Related]
4. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
[TBL] [Abstract][Full Text] [Related]
5. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
[TBL] [Abstract][Full Text] [Related]
6. Time-dependence of survival predictions based on markers of HIV disease. Swiss HIV Cohort Study.
Perneger TV; Abrahamowicz M; Bartlett G; Yerly S
J Investig Med; 2000 May; 48(3):207-12. PubMed ID: 10822902
[TBL] [Abstract][Full Text] [Related]
7. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
[TBL] [Abstract][Full Text] [Related]
8. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
9. Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia.
Wachtman LM; Skolasky RL; Tarwater PM; Esposito D; Schifitto G; Marder K; McDermott MP; Cohen BA; Nath A; Sacktor N; Epstein LG; Mankowski JL; McArthur JC
Arch Neurol; 2007 Sep; 64(9):1264-72. PubMed ID: 17846264
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
11. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS).
Farinpour R; Miller EN; Satz P; Selnes OA; Cohen BA; Becker JT; Skolasky RL; Visscher BR
J Clin Exp Neuropsychol; 2003 Aug; 25(5):654-70. PubMed ID: 12815503
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.
McCoig C; Castrejón MM; Saavedra-Lozano J; Castaño E; Báez C; Lanier ER; Sáez-Llorens X; Ramilo O
Pediatr Infect Dis J; 2004 Feb; 23(2):114-8. PubMed ID: 14872175
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort.
Bénet T; D'Oliveira A; Voirin N; Livrozet JM; Cotte L; Peyramond D; Chidiac C; Touraine JL; Fabry J; Trepo C; Allard R; Vanhems P
J Viral Hepat; 2007 Oct; 14(10):730-5. PubMed ID: 17875008
[TBL] [Abstract][Full Text] [Related]
16. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
Ho C; Lee S; Wong Kh; Cheng L; Lam M
HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy.
Savès M; Morlat P; Chêne G; Peuchant E; Pellegrin I; Bonnet F; Bernard N; Lacoste D; Salamon R; Beylot J
Clin Immunol; 2001 Jun; 99(3):347-52. PubMed ID: 11358430
[TBL] [Abstract][Full Text] [Related]
19. The V118I mutation as a marker of advanced HIV infection and disease progression.
Zaccarelli M; Tozzi V; Lorenzini P; Forbici F; Narciso P; Ceccherini-Silberstein F; Trotta MP; Bertoli A; Liuzzi G; Marconi P; Mosti S; Perno CF; Antinori A
Antivir Ther; 2007; 12(2):163-8. PubMed ID: 17503658
[TBL] [Abstract][Full Text] [Related]
20. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
